Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
Menu
The LenSx platform
The LenSx femtosecond system for cataract surgery, as used at the London Eye Hospital. LenSx, based in California, was acquired in July 2010 by healthcare giant Alcon Labs in a deal which generated a huge return for investors at the time. Alcon is the dominant player in the global cataract surgery devices market with a 43 percent market share, thanks to its leading position in the IOL market as well as a significant presence in both ophthalmic viscoelastic devices and surgical platforms such as LenSx. Credit: LenSx/London Eye Hospital.
Copyright © 2019 SPIE EuropeDesigned by Kestrel Web Services